Penn spinout Tmunity Therapeutics raises another $35M
University of Pennsylvania spinoff company Tmunity Therapeutics Inc. has raised an additional $35 million from Kleiner Perkins and affiliates, bringing the total amount of its series A equity financing to $135 million.
Founded in 2015, Tmunity is developing next-generation T cell immunotherapies for fighting cancer and other diseases. Its scientific founders include Dr. Carl H. June, a CAR-T Pioneer who led the team at Penn that developed the personalized cellular therapy treatment for leukemia,…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: John George Source Type: news
More News: Cancer | Cancer & Oncology | Health Management | Immunotherapy | Leukemia | University of Pennsylvania